Guided Therapeutics (GTHP) Shares Issued (2016 - 2025)
Guided Therapeutics (GTHP) has disclosed Shares Issued for 14 consecutive years, with $307000.0 as the latest value for Q4 2025.
- Quarterly Shares Issued fell 42.62% to $307000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 36.77% year-over-year, with the annual reading at $567000.0 for FY2025, 32.1% down from the prior year.
- Shares Issued hit $307000.0 in Q4 2025 for Guided Therapeutics, down from $535000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $1.8 million in Q2 2021 to a low of -$1.8 million in Q3 2021.
- Historically, Shares Issued has averaged $191818.2 across 5 years, with a median of $300000.0 in 2024.
- Biggest five-year swings in Shares Issued: skyrocketed 6920.0% in 2021 and later plummeted 92.59% in 2022.
- Year by year, Shares Issued stood at -$1.8 million in 2021, then surged by 102.11% to $37000.0 in 2022, then skyrocketed by 1078.38% to $436000.0 in 2023, then rose by 22.71% to $535000.0 in 2024, then crashed by 42.62% to $307000.0 in 2025.
- Business Quant data shows Shares Issued for GTHP at $307000.0 in Q4 2025, $535000.0 in Q4 2024, and $300000.0 in Q3 2024.